Cytiva has acquired Precision NanoSystems, a Vancouver, Canada-based global leader in technologies, solutions, and services to support nanomedicine development for genomic medicine applications, including mRNA vaccines and therapeutics.

Accelerate your pipeline with rationally designed LNP formulations to validate active pharmaceutical ingredients (API). We offer an easily accessible and well-characterized lipid nanoparticle portfolio and nanomedicine formulation technologies for mRNA vaccines and future RNA-based therapeutics.